IL232916A - 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine - Google Patents

6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine

Info

Publication number
IL232916A
IL232916A IL232916A IL23291614A IL232916A IL 232916 A IL232916 A IL 232916A IL 232916 A IL232916 A IL 232916A IL 23291614 A IL23291614 A IL 23291614A IL 232916 A IL232916 A IL 232916A
Authority
IL
Israel
Prior art keywords
oxazin
difluoromethyl
dihydro
amine derivatives
amine
Prior art date
Application number
IL232916A
Other languages
English (en)
Hebrew (he)
Other versions
IL232916A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL232916A0 publication Critical patent/IL232916A0/en
Publication of IL232916A publication Critical patent/IL232916A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL232916A 2011-12-05 2014-06-02 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine IL232916A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191997 2011-12-05
PCT/EP2012/074351 WO2013083557A1 (en) 2011-12-05 2012-12-04 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives

Publications (2)

Publication Number Publication Date
IL232916A0 IL232916A0 (en) 2014-08-03
IL232916A true IL232916A (en) 2016-07-31

Family

ID=47278317

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232916A IL232916A (en) 2011-12-05 2014-06-02 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine

Country Status (18)

Country Link
US (1) US20140343048A1 (enExample)
EP (1) EP2788346B1 (enExample)
JP (1) JP6169095B2 (enExample)
KR (1) KR102060379B1 (enExample)
CN (1) CN103974951B (enExample)
AU (1) AU2012347397B2 (enExample)
BR (1) BR112014013310A2 (enExample)
CA (1) CA2852366C (enExample)
EA (1) EA023909B1 (enExample)
ES (1) ES2558604T3 (enExample)
IL (1) IL232916A (enExample)
MX (1) MX357384B (enExample)
MY (1) MY165209A (enExample)
PH (1) PH12014501235A1 (enExample)
SG (1) SG11201402734XA (enExample)
UA (1) UA111749C2 (enExample)
WO (1) WO2013083557A1 (enExample)
ZA (1) ZA201404074B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637504B2 (en) 2008-06-13 2014-01-28 Shionogi & Co., Ltd. Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
RU2012129168A (ru) 2009-12-11 2014-01-20 Сионоги Энд Ко. Лтд. Производные оксазина
AR081587A1 (es) 2010-06-09 2012-10-03 Janssen Pharmaceutica Nv DERIVADOS DE 5,6-DIHIDRO-2H-[1,4]OXAZIN-3-IL-AMINA UTILES COMO INHIBIDORES DE LA b-SECRETASA (BACE)
ES2648143T3 (es) 2010-12-22 2017-12-28 Janssen Pharmaceutica Nv Derivados de 5,6-dihidro-imidazo[1,2-a]pirazin-8-ilamina útiles como inhibidores de la beta-secretasa (BACE)
JP5853035B2 (ja) 2011-03-09 2016-02-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap β−セクレターゼ(BACE)の阻害剤として有用な3,4−ジヒドロ−ピロロ[1,2−a]ピラジン−1−イルアミン誘導体
CN103974940B (zh) * 2011-12-06 2016-08-24 詹森药业有限公司 5-(3-氨基苯基)-5-烷基-5,6-二氢-2h-[1,4]噁嗪-3-胺衍生物
JP2016501827A (ja) 2012-10-24 2016-01-21 塩野義製薬株式会社 Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
EP3008067B1 (en) 2013-06-12 2017-03-29 Janssen Pharmaceutica N.V. 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2h)-one derivatives as inhibitors of beta-secretase (bace)
KR102243134B1 (ko) 2013-06-12 2021-04-22 얀센 파마슈티카 엔.브이. 베타-세크레타제(bace) 저해제로서의 4-아미노-6-페닐-5,6-디하이드로이미다조[1,5-a]피라진 유도체
BR112015030597A2 (pt) 2013-06-12 2017-07-25 Janssen Pharmaceutica Nv derivados 4-amino-6-fenil-6,7-di-hidro[1,2,3]triazolo[1,5-a]pirazina como inibidores de beta-secretase (bace)
JP2017538753A (ja) 2014-12-18 2017-12-28 ヤンセン ファーマシューティカ エヌ.ベー. 2,3,4,5−テトラヒドロピリジン−6−アミンおよび3,4−ジヒドロ−2H−ピロール−5−アミンの化合物のβセクレターゼ阻害剤
WO2021154599A1 (en) * 2020-01-27 2021-08-05 Silcotek Corp. Biopharmaceutical manufacturing process and product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32799A (es) 2009-07-24 2011-02-28 Novartis Ag Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos
US8188079B2 (en) 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
AR081587A1 (es) 2010-06-09 2012-10-03 Janssen Pharmaceutica Nv DERIVADOS DE 5,6-DIHIDRO-2H-[1,4]OXAZIN-3-IL-AMINA UTILES COMO INHIBIDORES DE LA b-SECRETASA (BACE)
CN103429589A (zh) * 2011-01-12 2013-12-04 诺瓦提斯公司 噁嗪衍生物及其在治疗神经障碍中的用途
WO2012147763A1 (ja) * 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するbace1阻害剤
CN103974940B (zh) * 2011-12-06 2016-08-24 詹森药业有限公司 5-(3-氨基苯基)-5-烷基-5,6-二氢-2h-[1,4]噁嗪-3-胺衍生物

Also Published As

Publication number Publication date
PH12014501235B1 (en) 2014-09-08
ZA201404074B (en) 2016-10-26
SG11201402734XA (en) 2014-06-27
US20140343048A1 (en) 2014-11-20
CA2852366C (en) 2020-02-18
CA2852366A1 (en) 2013-06-13
BR112014013310A2 (pt) 2017-06-13
IL232916A0 (en) 2014-08-03
UA111749C2 (uk) 2016-06-10
EP2788346A1 (en) 2014-10-15
JP6169095B2 (ja) 2017-07-26
ES2558604T3 (es) 2016-02-05
AU2012347397B2 (en) 2016-09-22
MX2014006689A (es) 2014-09-04
EA201491116A1 (ru) 2014-12-30
KR102060379B1 (ko) 2019-12-30
JP2015500223A (ja) 2015-01-05
EP2788346B1 (en) 2015-10-28
PH12014501235A1 (en) 2014-09-08
MX357384B (es) 2018-07-06
CN103974951B (zh) 2016-04-13
HK1198586A1 (zh) 2015-04-30
MY165209A (en) 2018-03-05
AU2012347397A1 (en) 2014-04-24
NZ626662A (en) 2015-05-29
WO2013083557A1 (en) 2013-06-13
EA023909B1 (ru) 2016-07-29
CN103974951A (zh) 2014-08-06
KR20140107209A (ko) 2014-09-04

Similar Documents

Publication Publication Date Title
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
ZA201401884B (en) New dihydroquinoline-2-one derivatives
SG10201601802YA (en) Dispiropyrrolidine derivatives
GB201204535D0 (en) .
GB201107176D0 (en) Pyrrolnitrin derivatives
ZA201404074B (en) 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
GB201216143D0 (en) .
SI2776436T1 (sl) Nove spojine
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
SG11201401937YA (en) New aryl-quinoline derivatives
IL247640A0 (en) History of heteroaryl piperidine
GB201203412D0 (en) .
IL232917A (en) Annals of 5 - (3-aminophenyl) -5-alkyl-6,5-dihydro-2h [4,1] oxazin-3-amine
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
EP2675773A4 (en) PROCESS FOR THE PREPARATION OF CIS-1-CHLORO-3,3,3-TRIFLUOROPROPENE
PT2771327T (pt) Novos derivados de pirazina
MY165626A (en) 1,2,4,-triazolone derivative
GB201203063D0 (en) .
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
IL232630A0 (en) A method for the preparation of 6,2-difluoroacetophenones
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives
GB201203786D0 (en) .

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed